The short version
14 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Oxaliplatin
Oxaliplatin · OXALIPLATIN 5 mg/mL · Injection, Solution · Intravenous · Eugia US LLC
NDC 55150-0331-01 · 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$0.0550per billing unit (0.5 MG)HCPCS J9263 · Jul 1, 2026
- Part D plans paid (avg)$55.47per dosage unitgross, before rebates — matched by drug name · 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$25.00
Reported to Texas DSHS · 2025 annual filing · Eugia Us Llc
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 0.5 MG
$0.055
HCPCS J9263 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2024)
$10,231
51 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $287.33 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA205529
- TE code
- —
- Approval date
- Sep 6, 2017
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)Jun 29, 2026
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)Jun 29, 2026
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)Oct 20, 2025
- Planned discontinuation — Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)Oct 20, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Oxaliplatin (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Fosun Pharma Usa Inc. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Meitheal Pharmaceuticals Inc. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Northstar Rx LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Sandoz Inc | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Shandong New Time Pharmaceutical Co., Ltd. | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| BluePoint Laboratories | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 200 mg/40mL | Jul 15, 2026 | Sep 2, 2026 |
| Qilu Pharmaceutical Co., Ltd. | OXALIPLATIN 50 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Eugia US LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Gland Pharma Limited | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
| Mylan Institutional LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
| NorthStar Rx LLC | OXALIPLATIN 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Oxaliplatin — NDC 55150-0331-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55150033101.
Free to cite with attribution — see how the data is put together.